Literature DB >> 32649262

Don't forget ototoxicity during the SARS-CoV-2 (Covid-19) pandemic!

Andrea Ciorba1, Virginia Corazzi1, Piotr Henryk Skarżyński2,3,4, Magdalena B Skarżyńska2,4, Chiara Bianchini1, Stefano Pelucchi1, Stavros Hatzopoulos1.   

Abstract

Aim of this communication is to remind clinical professionals to be aware of ototoxic side effects of several specific drugs proposed for the treatment of the new virus SARS-CoV-2 (Covid-19). In particular, chloroquine and hydroxychloroquine, azithromycin, as well as antiviral drugs such as remdesivir, favipiravir and lopinavir can all present potential ototoxic side effects. The data in the literature do not offer specific information on their potential synergetic effects nor on their interactions.

Entities:  

Keywords:  SARS-CoV-2 (Covid-19) pandemic; chloroquine; favipiravir; hydroxychloroquine; lopinavir; ototoxicity; remdesivir

Year:  2020        PMID： 32649262     DOI： 10.1177/2058738420941754

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN： 0394-6320            Impact factor:   3.219


  13 in total

Review 1.  ENT symptoms in acute COVID-19: a narrative review.

Authors:  Giancarlo Tirelli; Paolo Boscolo-Rizzo
Journal:  Acta Otorhinolaryngol Ital       Date:  2022-04       Impact factor: 2.618

2.  Changes in Tinnitus Experiences During the COVID-19 Pandemic.

Authors:  Eldré W Beukes; David M Baguley; Laure Jacquemin; Matheus P C G Lourenco; Peter M Allen; Joy Onozuka; David Stockdale; Viktor Kaldo; Gerhard Andersson; Vinaya Manchaiah
Journal:  Front Public Health       Date:  2020-11-05

3.  SARS-CoV-2 and hearing: An audiometric analysis of COVID-19 hospitalized patients.

Authors:  Francisco Alves de Sousa; Rodrigo Pinto Costa; Sandra Xará; Ana Nóbrega Pinto; Cecília Almeida E Sousa
Journal:  J Otol       Date:  2021-02-03

Review 4.  Ototoxicity of Non-aminoglycoside Antibiotics.

Authors:  Leonard P Rybak; Vickram Ramkumar; Debashree Mukherjea
Journal:  Front Neurol       Date:  2021-03-09       Impact factor: 4.003

5.  Blood Viscosity in COVID-19 Patients With Sudden Deafness.

Authors:  Francisco Javier García-Callejo; Ramón Balaguer-García; María Dolores Lis-Sancerni; Luis Ruescas-Gómez; Marta Murcia-López
Journal:  Acta Otorrinolaringol Esp (Engl Ed)       Date:  2022-02-23

6.  The effects of SARS-CoV-2 on hearing thresholds in COVID-19 patients with non-hospitalized mild disease.

Authors:  Osman Durgut; Mesut Karataş; Çağlar Çelik; Oğuzhan Dikici; Fevzi Solmaz; Sündüz Gencay
Journal:  Am J Otolaryngol       Date:  2021-12-14       Impact factor: 1.808

7.  Study of Hearing Status in COVID-19 Patients: A Multicentered Review.

Authors:  Subash Bhatta; Santosh Sharma; Dibya Sharma; Leison Maharjan; Sushma Bhattachan; Mukesh Kumar Sah; Aditya Singhal; Asheesh Dora Ghanpur; Dushyanth Ganesuni
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-07-12

8.  Mild and moderate COVID-19 disease does not affect hearing function permanently: a cross-sectional study ınvolving young and middle-aged healthcare givers.

Authors:  Kerem Kökoğlu; Nezaket Tektaş; Fidan Elif Baktir-Okcesiz; Mehmet İlhan Şahin
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-06-29       Impact factor: 2.503

9.  [Blood viscosity in COVID-19 patients with sudden deafness].

Authors:  Francisco Javier García-Callejo; Ramón Balaguer-García; María Dolores Lis-Sancerni; Luis Ruescas-Gómez; Marta Murcia-López
Journal:  Acta Otorrinolaringol Esp       Date:  2021-07-15

10.  SARS-CoV-2 (COVID-19) and audio-vestibular disorders.

Authors:  Virginia Fancello; Stavros Hatzopoulos; Virginia Corazzi; Chiara Bianchini; Magdalena B Skarżyńska; Stefano Pelucchi; Piotr Henryk Skarżyński; Andrea Ciorba
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.